Search results for "Uterine fibroids."

showing 3 items of 23 documents

Goserelin acetate to avoid hysterectomy in pre-menopausal women with fibroids requiring surgery

1999

Objective: To obtain information on the efficacy of repeated short cycles of GNRH agonist treatment in order to avoid hysterectomy in near-menopausal women with symptomatic fibroids. Study design: 72 pre-menopausal women (mean age 50 years) with one or more uterine fibroids >10 cm in diameter, symptomatic menorrhagia lasting three months or more and haemoglobin=9 g/dl entered the study. The patients were randomized with ratio of approximately 1:4 to: (a) immediate surgery; or (b) treatment with goserelin acetate. Patients randomized to goserelin acetate received a first cycle of 3.6 mg depot once every 28 days for four months. They were followed-up for three years. If menorrhagia was observ…

medicine.medical_specialtyFibroidsRandomizationUterine fibroidsmedicine.medical_treatmentOvariectomyHysterectomylaw.inventionGonadotropin-Releasing HormoneRandomized controlled triallawmedicineHumansFibroids; Hysterectomy; Medical treatmentMenorrhagiaGynecologyHysterectomyLeiomyomabusiness.industryGoserelinGoserelin AcetateObstetrics and GynecologyMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsSurgeryMenopauseLeiomyomaReproductive MedicinePremenopauseGoserelinFemalebusinessMedical treatmentmedicine.drugHuman
researchProduct

A Semi-automatic Multi-seed Region-Growing Approach for Uterine Fibroids Segmentation in MRgFUS Treatment

2013

Fibroids are benign tumors growing in the uterus. Most of fibroids do not require treatment unless they are causing symptoms. Traditional surgery treatments, like myomectomy and hysterectomy, are very invasive therapeutic approaches which not always preserves reproductive potential of the woman. MRgFUS, performed with Insightec ExAblate 2100 equipment, is a new and noninvasive technique for uterine fibroids treatment, not requiring hospitalization and recovery time for patients. An initial assessment of MRgFUS treatment is made by computing the ablated volume of uterine fibroid. In this paper a semi-automatic approach, based on region-growing segmentation technique, is proposed. The impleme…

medicine.medical_specialtyHysterectomyMRgFUSUterine fibroidsComputer scienceExAblatemedicine.medical_treatmentmedicine.diseasefemale genital diseases and pregnancy complicationsSegmentationTreatment evaluationArtificial IntelligenceRegion growingMDSSmedicineRegion-growingReproductive potential3D volume reconstructionUterine fibroidSegmentationSemi automaticRadiologySoftware2013 Seventh International Conference on Complex, Intelligent, and Software Intensive Systems
researchProduct

Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study

2020

Objective: This study aimed to analyze the effects of a six-month therapy with ulipristal acetate (UPA) on myoma size and endometrial thickness in premenopausal women. Material and methods: Seventy-four women undergoing conservative therapy with UPA were enrolled for this study. All women underwent transvaginal ultrasound evaluation to assess the endometrial thickness, and the number and size of myomas at the beginning and after six months. Hysteroscopy and biopsy were performed after six months, if necessary. Results: After six months of treatment, sonographic examination showed a statistically significant (p <.05) reduction of the size of the largest myoma (56.3 ± 5.1 vs. 31.7 ± 10.1 m…

medicine.medical_specialtyNorpregnadienesUterine fibroidsHysteroscopy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePregnancyUlipristal acetateSelective progesterone receptor modulatorulipristal acetatemedicineHumansProspective Studiesuterine fibroidsProspective cohort studyGynecologyLeiomyomamedicine.diagnostic_testbusiness.industryMetrorrhagiaMyomaselective progesterone receptor modulatormedicine.diseaseMyomachemistryHysteroscopy030220 oncology & carcinogenesisUterine NeoplasmsFemale030211 gastroenterology & hepatologySurgerymedicine.symptombusinessmetrorrhagia
researchProduct